Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2018 Feb 2;24(6):1187–1195. doi: 10.1016/j.bbmt.2018.01.039

Figure 1.

Figure 1.

Disposition of patients with NHL included in the 3101 LTF study

*‘Does not include 13 patients who received rituximab (patients were part of a Study 3101 substudy) or 9 patients who withdrew prior to receiving plerixafor or placebo.

All rescue patients received plerixafor.

Patients censored in the OS analysis at last date where data were available.